Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Hyperimmunoglobulin E syndromes in pediatrics.

Zhang Q, Su HC.

Curr Opin Pediatr. 2011 Dec;23(6):653-8. doi: 10.1097/MOP.0b013e32834c7f65. Review.

2.

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.

Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz V, Kreilinger D, Spielberger BD, Schimke-Marques LF, Sawalle-Belohradsky J, Belohradsky BH, Przybilla B, Schaub B, Wollenberg A, Renner ED.

Allergy. 2014 Jul;69(7):943-53. doi: 10.1111/all.12416.

3.

Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.

Hagl B, Heinz V, Schlesinger A, Spielberger BD, Sawalle-Belohradsky J, Senn-Rauh M, Magg T, Boos AC, Hönig M, Schwarz K, Dückers G, von Bernuth H, Pache C, Karitnig-Weiss C, Belohradsky BH, Frank J, Niehues T, Wahn V, Albert MH, Wollenberg A, Jansson AF, Renner ED.

Pediatr Allergy Immunol. 2016 Mar;27(2):177-84. doi: 10.1111/pai.12512. Epub 2016 Jan 26.

PMID:
26592211
4.

The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.

Engelhardt KR, Gertz ME, Keles S, Schäffer AA, Sigmund EC, Glocker C, Saghafi S, Pourpak Z, Ceja R, Sassi A, Graham LE, Massaad MJ, Mellouli F, Ben-Mustapha I, Khemiri M, Kilic SS, Etzioni A, Freeman AF, Thiel J, Schulze I, Al-Herz W, Metin A, Sanal Ö, Tezcan I, Yeganeh M, Niehues T, Dueckers G, Weinspach S, Patiroglu T, Unal E, Dasouki M, Yilmaz M, Genel F, Aytekin C, Kutukculer N, Somer A, Kilic M, Reisli I, Camcioglu Y, Gennery AR, Cant AJ, Jones A, Gaspar BH, Arkwright PD, Pietrogrande MC, Baz Z, Al-Tamemi S, Lougaris V, Lefranc G, Megarbane A, Boutros J, Galal N, Bejaoui M, Barbouche MR, Geha RS, Chatila TA, Grimbacher B.

J Allergy Clin Immunol. 2015 Aug;136(2):402-12. doi: 10.1016/j.jaci.2014.12.1945. Epub 2015 Feb 25.

5.

Clinical manifestations of hyper IgE syndromes.

Freeman AF, Holland SM.

Dis Markers. 2010;29(3-4):123-30. doi: 10.3233/DMA-2010-0734. Review.

6.

Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, Camcioglu Y, Cokugras H, Somer A, Kutukculer N, Yilmaz M, Ikinciogullari A, Yegin O, Yüksek M, Genel F, Kucukosmanoglu E, Baki A, Bahceciler NN, Rambhatla A, Nickerson DW, McGhee S, Barlan IB, Chatila T.

J Allergy Clin Immunol. 2009 Aug;124(2):342-8, 348.e1-5. doi: 10.1016/j.jaci.2009.05.004. Epub 2009 Jul 3.

7.

Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes.

Freeman AF, Holland SM.

Pediatr Res. 2009 May;65(5 Pt 2):32R-37R. doi: 10.1203/PDR.0b013e31819dc8c5. Review.

8.

Pathogenesis of hyper IgE syndrome.

Heimall J, Freeman A, Holland SM.

Clin Rev Allergy Immunol. 2010 Feb;38(1):32-8. doi: 10.1007/s12016-009-8134-1. Review.

PMID:
19452285
9.

[Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].

Heropolitańska-Pliszka E, Pietrucha B, Mikołuć B, Bernatowska E.

Med Wieku Rozwoj. 2009 Jan-Mar;13(1):19-25. Review. Polish.

PMID:
19648655
10.

Primary Immunodeficiencies with Elevated IgE.

Mogensen TH.

Int Rev Immunol. 2016;35(1):39-56. doi: 10.3109/08830185.2015.1027820. Epub 2015 May 13. Review.

PMID:
25970001
11.

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sánchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, Baumann U, Bacchetta R, Hsu AP, Davis JN, Hammarström L, Davies EG, Eren E, Arkwright PD, Moilanen JS, Viemann D, Khan S, Maródi L, Cant AJ, Freeman AF, Puck JM, Holland SM, Grimbacher B.

J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8. doi: 10.1016/j.jaci.2009.10.059.

12.

An update on the hyper-IgE syndromes.

Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B.

Arthritis Res Ther. 2012 Nov 30;14(6):228. doi: 10.1186/ar4069. Review.

13.

Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care.

Farmand S, Sundin M.

Curr Opin Hematol. 2015 Jan;22(1):12-22. doi: 10.1097/MOH.0000000000000104. Review.

PMID:
25469836
14.

Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.

Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, Barber JS, Freeman AF, Holland SM, O'Brien M, Jones N, Nelson CG, Wisch LB, Kong HH, Desai A, Farber O, Gilfillan AM, Rivera J, Milner JD.

J Allergy Clin Immunol. 2013 Dec;132(6):1388-96. doi: 10.1016/j.jaci.2013.08.045. Epub 2013 Nov 1. Erratum in: J Allergy Clin Immunol. 2014 Apr;133(4):1232. Nelson, Celeste G [added].

15.

Expansion of CCR4+ activated T cells is associated with memory B cell reduction in DOCK8-deficient patients.

Caracciolo S, Moratto D, Giacomelli M, Negri S, Lougaris V, Porta F, Pajno G, Salpietro A, Montin D, Dinwiddie DL, Kingsmore SF, Plebani A, Badolato R.

Clin Immunol. 2014 May-Jun;152(1-2):164-70. doi: 10.1016/j.clim.2014.03.008. Epub 2014 Mar 24.

PMID:
24674883
16.

Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.

Saikia B, Suri D, Goel S, Rawat A, Minz RW, Gupta A, Sharma S, Ohara O, Imai K, Nonoyama S, Sehgal S, Singh S.

Asian Pac J Allergy Immunol. 2014 Dec;32(4):321-7. doi: 10.12932/AP0456.32.4.2014.

17.

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.

Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz V, Kreilinger D, Spielberger BD, Schimke-Marques LF, Sawalle-Belohradsky J, Belohradsky BH, Przybilla B, Schaub B, Wollenberg A, Renner ED.

Allergy. 2014 May 20. doi: 10.1111/all.12416.. [Epub ahead of print]

18.

Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.

Paulson ML, Freeman AF, Holland SM.

Curr Opin Allergy Clin Immunol. 2008 Dec;8(6):527-33. doi: 10.1097/ACI.0b013e3283184210. Review.

PMID:
18978467
19.

Quantitative defects in invariant NKT cells and TLR responses in patients with hyper-IgE syndrome.

Gutierrez-Hincapié S, Muskus-López CE, Montoya CJ, Trujillo-Vargas CM.

Allergol Immunopathol (Madr). 2015 Nov-Dec;43(6):553-61. doi: 10.1016/j.aller.2014.11.002. Epub 2015 Mar 19.

PMID:
25796310
20.

Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.

Ives ML, Ma CS, Palendira U, Chan A, Bustamante J, Boisson-Dupuis S, Arkwright PD, Engelhard D, Averbuch D, Magdorf K, Roesler J, Peake J, Wong M, Adelstein S, Choo S, Smart JM, French MA, Fulcher DA, Cook MC, Picard C, Durandy A, Tsumura M, Kobayashi M, Uzel G, Casanova JL, Tangye SG, Deenick EK.

J Allergy Clin Immunol. 2013 Aug;132(2):400-11.e9. doi: 10.1016/j.jaci.2013.05.029. Epub 2013 Jul 4.

Supplemental Content

Support Center